翔宇SUNHOVER品牌怎么样 申请店铺

我要投票 翔宇SUNHOVER在滋补食材药材行业中的票数:371 更新时间:2025-08-14
翔宇SUNHOVER是哪个国家的品牌?「翔宇SUNHOVER」是 翔宇药业股份有限公司 旗下著名品牌。该品牌发源于山东省临沂市,由创始人林董在1999年期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力翔宇SUNHOVER品牌出海!将品牌入驻外推网,定制翔宇SUNHOVER品牌推广信息,可以显著提高翔宇SUNHOVER产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

翔宇SUNHOVER怎么样

翔宇药业股份有限公司,山东省著名商标,孕产妇儿童补血知名品牌,高新技术企业,大型现代化民营制药企业


翔宇药业股份有限公司是翔宇集团控股上市公司,下辖一家全资子公司(山东仁和堂药业有限公司)和一家控股公司(山东诺维尔斯医药科技有限公司两家子公司)。拥有中药健康园、仁和堂化药园两大生产基地。生产妇科、儿科、精神、补益、心脑血管等11类制剂及原料药138个品种300多个品规。具有自主知识产权、自主定价权、国家中药保护品种及进入国家医保、基药、新农合目录的药品200多个。

翔宇药业坚持“打造中国妇幼用药一线药企”的企业发展战略,目前已经与3000多个经销商、100000多家医疗药店终端展开合作,销售网络遍布全国,部分产品远销欧美,为越来越多的家庭提供专业、优质的产品和服务!

化药盐酸地芬尼多取得美国DMF注册,盐酸米安色林、乳酸氟罗沙星原料药为国内独家产品替代进口,产品销往日本、墨西哥、美国等多个国家和地区。

翔宇药业严格按照新版GMP的要求设计,实施高标准GMP生产体系和质量体系,执行高于国标的内控标准。近年来,先后投入3.5亿元升级改造生产系统、生态处理系统。新建多功能提取车间及综合固体制剂车间,引进自动化控制系统、国际先进的药品检测设备,确保产品质量的稳定和优良。


Xiangyu Pharmaceutical Co., Ltd., a famous trademark of Shandong Province, a well-known brand of maternal and child blood supplement, a high-tech enterprise, and a large modern private pharmaceutical enterprise, Xiangyu Pharmaceutical Co., Ltd. is a listed company controlled by Xiangyu Group, which has a wholly-owned subsidiary (Shandong Renhetang Pharmaceutical Co., Ltd.) and a holding company (Shandong novels Pharmaceutical Technology Co., Ltd.) Subsidiaries). There are two production bases of Chinese medicine health park and Renhetang pharmaceutical park. More than 300 specifications of 138 varieties of 11 kinds of preparations and APIs, including Gynecology, pediatrics, spirit, tonic, cardio cerebrovascular and so on, are produced. There are more than 200 drugs with independent intellectual property rights, independent pricing rights, national protected varieties of traditional Chinese medicine and entering the national medical insurance, basic medicine and new rural cooperative medical insurance catalogue. Xiangyu pharmaceutical adheres to the enterprise development strategy of "building a first-line pharmaceutical enterprise of Chinese maternal and child medicine". At present, it has cooperated with more than 3000 distributors and 100000 Medical Pharmacy terminals. Its sales network spreads all over the country, and some products are exported to Europe and America, providing more and more families with professional and high-quality products and services! Difenidol hydrochloride, a chemical drug, has been registered with DMF in the United States. The raw materials of mianserin hydrochloride and fleroxacin lactate are the exclusive products in China, which are sold to Japan, Mexico, the United States and other countries and regions. Xiangyu pharmaceutical has designed in strict accordance with the requirements of the new GMP, implemented a high standard GMP production system and quality system, and implemented internal control standards higher than the national standard. In recent years, 350 million yuan has been invested in upgrading production system and ecological treatment system. New multi-functional extraction workshop and comprehensive solid preparation workshop, introduction of automatic control system, international advanced drug testing equipment, to ensure the stability and excellence of product quality.

本文链接: https://brand.waitui.com/c76e2d7a6.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

热门中概股美股盘前多数下跌,网易跌超6%

36氪获悉,热门中概股美股盘前多数下跌,截至发稿,网易跌超6%,阿里巴巴、百度、B站、蔚来跌超2%,理想汽车、小鹏汽车、腾讯音乐、爱奇艺跌超1%,京东跌0.65%;微博涨超3%。

53分钟前

中水渔业:上半年归母净利润8631.02万元,同比增长22.12%

36氪获悉,中水渔业披露半年报,公司上半年实现营业收入17.47亿元,同比下降10.66%;归属于上市公司股东的净利润8631.02万元,同比增长22.12%;基本每股收益0.2359元。

53分钟前

芯海科技:拟发行H股并在香港联交所主板上市

36氪获悉,芯海科技公告,公司拟在境外发行股份并在香港联合交易所有限公司主板上市。公司将充分考虑现有股东的利益和境内外资本市场的情况,在股东大会决议有效期内选择适当的时机和发行窗口完成本次发行H股并上市。

53分钟前

*ST铖昌:上半年度净利润为5663万元,实现扭亏为盈

36氪获悉,*ST铖昌公告,公司2025年上半年实现营业收入2.01亿元,同比增长180.16%。归属于上市公司股东的净利润为5663.33万元,实现扭亏为盈。

53分钟前

金固股份:与鹿明机器人签订战略合作框架协议

36氪获悉,金固股份公告,公司与鹿明机器人科技(深圳)有限公司签订《战略合作框架协议》,拟结为战略合作伙伴关系,共同探索阿凡达铌微合金在四足机器人、人形机器人等产品上进行新材料在机身零部件的应用开发与拓展。该协议为初步框架协议,不涉及具体金额,预计对公司本年度经营业绩不构成重大影响。

53分钟前

本页详细列出关于翔宇SUNHOVER的品牌信息,含品牌所属公司介绍,翔宇SUNHOVER所处行业的品牌地位及优势。
咨询